Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 6, 2017
Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose ReinforcementMichael Michaelides, Michael L Miller, Jennifer A DiNieri, et al.
Neuropharmacology|June 9, 2015
Differential effects of ghrelin antagonists on alcohol drinking and reinforcement in mouse and rat models of alcohol dependenceJuan L Gomez, Christopher L Cunningham, Deborah A Finn, et al.
Iscience|June 8, 2026
Sigma-1 receptor promotes glycolysis in neuronal systems by suppressing GRIM19Simon Couly, Yuko Yasui, Ioannis Grammatikakis, et al.
Science (New York, N.Y.)|March 16, 2019
Ultrapotent chemogenetics for research and potential clinical applicationsChristopher J Magnus, Peter H Lee, Jordi Bonaventura, et al.
Molecular Imaging and Biology|August 23, 2022
6-O-(2-[18F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([18F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In VivoMarjorie R Levinstein, Emilya N Ventriglia, Juan L Gomez, et al.
Scientific Reports|January 22, 2024
Synthesis and preclinical evaluation of [11C]uPSEM792 for PSAM4-GlyR based chemogeneticsSridhar Goud Nerella, Sanjay Telu, Jeih-San Liow, et al.
Biological Psychiatry|February 25, 2023
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse LiabilityMarjorie R Levinstein, Meghan L Carlton, Tommaso Di Ianni, et al.
Molecular Psychiatry|April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liabilityJordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Pageof 5